Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

REXTON RX12 POWER PLUS W/DUAL RECEIVER

K-Number: K901341 · 1990-07-27

ApplicantRexton, Inc.
Decision Date1990-07-27
Product CodeESD
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

REXTON RX12 POWER PLUS W/DUAL RECEIVER is the device name listed in this FDA 510(k) record. The listed applicant is Rexton, Inc.. It received FDA 510(k) clearance on 1990-07-27 under 510(k) number K901341. The device is classified under product code ESD. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the REXTON RX12 POWER PLUS W/DUAL RECEIVER?

REXTON RX12 POWER PLUS W/DUAL RECEIVER is a medical device that received FDA 510(k) clearance on 1990-07-27. The listed applicant is Rexton, Inc.. The 510(k) number is K901341.

When did REXTON RX12 POWER PLUS W/DUAL RECEIVER receive FDA 510(k) clearance?

REXTON RX12 POWER PLUS W/DUAL RECEIVER received FDA 510(k) clearance on 1990-07-27, under 510(k) number K901341.

Who is the listed applicant for REXTON RX12 POWER PLUS W/DUAL RECEIVER?

The FDA 510(k) record lists Rexton, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for REXTON RX12 POWER PLUS W/DUAL RECEIVER?

The FDA product code for REXTON RX12 POWER PLUS W/DUAL RECEIVER is ESD.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Rexton, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K970537REXTON MODEL 48 AND 49PPK964451PICCOLO K-AMP VC+, PICCOLO P-A1, PICCOLO P-AO AND PICCOLO ATCK960295LONG LIFE RX-12K954922REXTON'S HORIZION FAMILY OF MULTIPLE SITUATION, SINGLE CHANNEL PROGRAMMBALE INSTRUMENTSK953770REXTON MINI-PRIMO PLUS, PP142, D.C .H.I. FAMILYK950451M-29 PP-PC, M-29 PP-O/PC

View all 21 devices →

Related Devices (Code: ESD)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K232999Lyric4 Hearing AidSonova AGK130790LYRIC2Phonak, LLCK081136LYRIC HEARING AIDInsound Medical, Inc.K021867INSOUND XT SERIES HEARING AIDInsound Medical, Inc.K003558TCI COMBI (TINNITUS CONTROL INSTRUMENT COMBINATION)Siemens Hearing Instruments, Inc.K984518SONIC INNOVATIONS COMPLETELY-IN-THE-CANAL DSP HEARING AID WITH SOFT SHELLSonic Innovations, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑